Back to Search

REGN

Regeneron Pharmaceuticals Inc
Data: 2026-10-23
$805.02
Price
-1.72%
Change
$859.34
52W High
$572.75
52W Low
Full AI Analysis Buy/Sell Forecast Trendline Why Moving Charts Options
Analyzing positioning… Options positioning — based on yesterday's biggest open-interest changes See the chart Institutional flows
Track record
signal day → next-day price move
Quick Stats
Oct 23, 2026

34.5

AI Score

AVOID NEW MONEY

0.73

Volume Ratio

Oct 30, 2026

Next Earnings

15

+ve Days (30d)

15

-ve Days (30d)

REGN Price vs Max Options Open Interest

How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.

REGN Max Change In Options Open Interest

How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.

REGN Options - Sort by Max open Interest (near term)

24th October 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

REGN Daily Out of Money Options - Sort by Max open Interest (near term)

24th October 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

REGN Daily In the Money Options - Sort by Max open Interest (near term)

24th October 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

REGN Most Active Options by Volume(near term)

24th October 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track
REGN Technical Chart Pro Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select an indicator above — it will be added as a pane under the price chart with aligned dates.

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

REGN Stock Summary

Last updated Oct 23, 2026

REGN is currently trading at $805.02, positioned above its 200-day moving average of $736.01, indicating a long-term uptrend. The stock has a 52-week range of $572.75 to $859.34.

Technical Analysis: The 50-day moving average stands at $791.37, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 58.066, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.001, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates REGN at 34.5/100 with a AVOID NEW MONEY recommendation.

REGN (Regeneron Pharmaceuticals Inc) Indicators

Last updated Oct 23, 2026

Indicator Value
RSI(14) 58.066
CMF (20) 0.001
ROC (10) 7.833
ADX (14) 21.416
Indicator Value
MACD (12,26,9) 8.588
AROONOSC (14) 92.857
WILLAMS %R (14) -20.123
MFI (14) 68.422

REGN Candlestick Patterns

No validated candlestick patterns fired for REGN in the last 10 sessions — that's normal. Only the ~15 patterns with a backtested edge (out of 60 textbook patterns) are tracked here.

Regeneron Pharmaceuticals Inc is above both the 50 Day and 200 Day SMA which is considered Bullish.

REGN Moving Averages Analysis

Regeneron Pharmaceuticals Inc has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Oct 23, 2026

Regeneron Pharmaceuticals Inc has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Oct 23, 2026

REGN (Regeneron Pharmaceuticals Inc) Simple Moving Averages

Moving Averages are last updated Oct 23, 2026

Days MA
10 790.07
20 766.26
30 774.33
50 791.37
100 731.73
200 736.01

REGN Fundamental Analysis

P/E (Forward) 14.5138
P/E (Trailing) 20.2545
Market Cap ($) 84.3 billion
Earnings/Share ($) 40.44
Net Profit Margin (%) 0.2787
Dividend/Share ($) 3.64
EPS Estimate Current Year ($) 59.1298
EPS Estimate Next Year ($) 52.0286
WallStreet Target Price ($) 867.33
Most Recent Quarter

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).